dc.contributor.author |
Khaziakhmetova V. |
|
dc.contributor.author |
Miryakupova S. |
|
dc.contributor.author |
Dzhamalbekov A. |
|
dc.contributor.author |
Baiysbekov K. |
|
dc.contributor.author |
Torobekov S. |
|
dc.contributor.author |
Ziganshina L. |
|
dc.date.accessioned |
2018-09-19T22:59:43Z |
|
dc.date.available |
2018-09-19T22:59:43Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
2191-1630 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/145887 |
|
dc.description.abstract |
© 2016, Springer Science+Business Media New York.Prophylactic administration to rats with the model of chronic autoimmune inflammation, induced by Freund’s adjuvant, of a typical neuroleptic haloperidol at a dose of 0.1 mg/kg increased the intensity of the primary inflammatory response (arthritis) and inhibited progression of the secondary arthritis. |
|
dc.relation.ispartofseries |
BioNanoScience |
|
dc.subject |
Chronic autoimmune inflammation |
|
dc.subject |
Freund’s adjuvant |
|
dc.subject |
Haloperidol |
|
dc.subject |
Rats |
|
dc.title |
The Effects of Haloperidol on the Progression of Chronic Autoimmune Inflammation Induced by Freund’s Adjuvant |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
2 |
|
dc.relation.ispartofseries-volume |
7 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
428 |
|
dc.source.id |
SCOPUS21911630-2017-7-2-SID85019101021 |
|